60.36
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
26.55%
4.0931
|
3.2343 | 3.2218 | 11.07 | 1.5749 |
| Operating Income/Loss |
26.55%
-4.0931
|
-3.2343 | -3.2218 | -11.07 | -1.5749 |
| Income/Loss From Continuing Operations Before Tax |
40.11%
-3.4376
|
-2.4535 | -2.625 | -10.92 | -1.3043 |
| Income/Loss From Continuing Operations After Tax |
40.11%
-3.4376
|
-2.4535 | -2.625 | -10.93 | -1.3043 |
|
|
40.11%
-3.4376
|
-2.4535 | -2.625 | -10.93 | -1.3043 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.80%
7.1238
|
6.9981 | 6.9874 | 0.3709 | 3.5204 |
| Basic Earnings Per Share |
37.14%
-0.48
|
-0.35 | -0.38 | -2.75 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):